We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+4.15%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$12.2B
AUM Growth
+$1.52B
Cap. Flow
+$1.17B
Cap. Flow %
9.66%
Top 10 Hldgs %
19.97%
Holding
2,123
New
434
Increased
455
Reduced
367
Closed
827

Top Buys

Rank Stock Value
1
BSX icon
Boston Scientific
BSX
+$197M
2
BABA icon
Alibaba
BABA
+$190M
3
AMZN icon
Amazon
AMZN
+$161M
4
GDDY icon
GoDaddy
GDDY
+$135M
5
DIS icon
Walt Disney
DIS
+$132M

Sector Composition

Rank Sector Weight
1 Healthcare 24.88%
2 Consumer Discretionary 23.99%
3 Technology 11.1%
4 Financials 8.14%
5 Industrials 7.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SPLK
1951
DELISTED
Splunk Inc
SPLK
-20
Closed -$2K
MDRX
1952
DELISTED
Veradigm Inc. Common Stock
MDRX
-25,795
Closed -$246K
MRTX
1953
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
-4,853
Closed -$356K
BVH
1954
DELISTED
Bluegreen Vacations Holding Corporation
BVH
-13,289
Closed -$393K
LTHM
1955
DELISTED
Livent Corporation
LTHM
-4,232
Closed -$52K
FTCH
1956
DELISTED
Farfetch Limited Class A Ordinary Shares
FTCH
-220,331
Closed -$5.93M
AAIC
1957
DELISTED
Arlington Asset Investment Corp.
AAIC
-92,582
Closed -$737K
CORR
1958
DELISTED
CorEnergy Infrastructure Trust, Inc.
CORR
-8,866
Closed -$326K
HEP
1959
DELISTED
Holly Energy Partners, L.P.
HEP
-867
Closed -$23K
VRTV
1960
DELISTED
VERITIV CORPORATION
VRTV
-12,947
Closed -$341K
GHL
1961
DELISTED
Greenhill & Co., Inc.
GHL
-1,512
Closed -$33K
LHC.U
1962
DELISTED
Leo Holdings Corp. II Units, each consisting of one Class A ordinary share and one-quarter of one redeemable warrant
LHC.U
-600,000
Closed -$6.23M
AVID
1963
DELISTED
Avid Technology Inc
AVID
-43,474
Closed -$324K
CIR
1964
DELISTED
CIRCOR International, Inc
CIR
-10,560
Closed -$344K
HCCI
1965
DELISTED
Heritage-Crystal Clean, Inc.
HCCI
-16,590
Closed -$455K
MMP
1966
DELISTED
Magellan Midstream Partners, L.P.
MMP
-26,164
Closed -$1.59M
INFI
1967
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
-18,606
Closed -$35K
WWE
1968
DELISTED
World Wrestling Entertainment
WWE
-2,190
Closed -$190K
QUOT
1969
DELISTED
Quotient Technology Inc
QUOT
-9,635
Closed -$95K
MTEM
1970
DELISTED
Molecular Templates, Inc.
MTEM
-2,566
Closed -$224K
VRAY
1971
DELISTED
ViewRay, Inc.
VRAY
-131,179
Closed -$970K
USX
1972
DELISTED
U.S. Xpress Enterprises, Inc. Class A Common Stock
USX
-51,142
Closed -$338K
BLCM
1973
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
-5
Closed
MNTV
1974
DELISTED
Momentive Global Inc. Common Stock
MNTV
-13,606
Closed -$248K
SIOX
1975
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
-25,609
Closed -$272K

Similar funds

Marshall Wace's Q2 2019 Portfolio in Review

As of Q2 2019, Marshall Wace held 2,123 positions worth $12.2B, up 14% from $10.6B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Marshall Wace deployed $1.17B of net new capital in Q2 2019, opening 434 new positions and adding to 455 existing holdings. Its largest new stake was EPAM Systems: 482,974 shares worth $83.6M.

By sector, the portfolio is most concentrated in Healthcare at 25% of assets, up from 21% a quarter earlier, followed by Consumer Discretionary and Technology.

On the sell side, the largest reduction was Alphabet (Google) Class A, an estimated $122M trimmed.

  • Marshall Wace's largest Q2 2019 buy was EPAM Systems: 482,974 shares worth $83.6M.
  • Marshall Wace added most to Boston Scientific in Q2 2019, an estimated $197M increase.
  • Marshall Wace's biggest Q2 2019 reduction was Alphabet (Google) Class A, cutting an estimated $122M.
  • Marshall Wace fully exited iShares MSCI Emerging Markets ETF in Q2 2019, selling an estimated $69.5M.
  • Marshall Wace's ten largest holdings make up 20% of its $12.2B portfolio in Q2 2019.
  • Marshall Wace opened 434 new positions and closed 827 in Q2 2019.
  • Marshall Wace's portfolio value rose 14% quarter-over-quarter to $12.2B.

Based on Marshall Wace's 13F filing for Q2 2019, filed 14 Aug 2019.